Clinical Trial Update: Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares two teriparatide formulations, Osteofortil and Forteo, for efficacy and safety in postmenopausal osteoporosis with pathologica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Forteo (teriparatide)
• Osteofortil (teriparatide)

Snippet

Sponsor: Bio Sidus SA | Conditions: Postmenopausal Osteoporosis With Pathological Fracture | Phase 4 | Status: UNKNOWN